Use of renin–angiotensin–aldosterone system inhibitors and risk of COVID-19 requiring admission to hospital: a case-population study

BACKGROUND: Concerns have been raised about the possibility that inhibitors of the renin–angiotensin–aldosterone system (RAAS) could predispose individuals to severe COVID-19; however, epidemiological evidence is lacking. We report the results of a case-population study done in Madrid, Spain, since...

Descripción completa

Detalles Bibliográficos
Autores principales: de Abajo, Francisco J, Rodríguez-Martín, Sara, Lerma, Victoria, Mejía-Abril, Gina, Aguilar, Mónica, García-Luque, Amelia, Laredo, Leonor, Laosa, Olga, Centeno-Soto, Gustavo A, Ángeles Gálvez, Maria, Puerro, Miguel, González-Rojano, Esperanza, Pedraza, Laura, de Pablo, Itziar, Abad-Santos, Francisco, Rodríguez-Mañas, Leocadio, Gil, Miguel, Tobías, Aurelio, Rodríguez-Miguel, Antonio, Rodríguez-Puyol, Diego
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Ltd. 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7255214/
https://www.ncbi.nlm.nih.gov/pubmed/32416785
http://dx.doi.org/10.1016/S0140-6736(20)31030-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7255214/
https://www.ncbi.nlm.nih.gov/pubmed/32416785
http://dx.doi.org/10.1016/S0140-6736(20)31030-8

Ejemplares similares